Orion Pharma’s power subsidiaries seek extension
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
March 31, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, MARCH 31, 2023
Orion Pharma’s power subsidiaries seek extension

Corporates

TBS Report
02 June, 2021, 10:05 pm
Last modified: 02 June, 2021, 10:12 pm

Related News

  • Orion Pharma greets FCPS doctors
  • Orion Pharma: Un-Audited Half Yearly (Q2) Financial Statements
  • Orion Pharma awards 5 doctors for winning Football World Cup quiz contest
  • Orion Pharma holds strategic meeting for 2023
  • Orion Pharma: Price Sensitive Information

Orion Pharma’s power subsidiaries seek extension

The contract of one of the plants has already expired in May and the other will follow in July this year

TBS Report
02 June, 2021, 10:05 pm
Last modified: 02 June, 2021, 10:12 pm
Orion Pharma’s power subsidiaries seek extension

Orion Pharma Ltd has informed its shareholders that its two power generation subsidiaries are looking for contract renewal with the government.

The contract of one of the plants has already expired in May and the other will follow in July this year.

In a stock exchange disclosure on Wednesday, the listed drugmaker said, Orion Power Meghnaghat Ltd's power purchasing agreement (PPA) with the Bangladesh Power Development Board (BPDB) to supply electricity to the national grid has expired in May.

The other plant built, owned and operated by Orion Pharma's subsidiary Dutch Bangla Power & Associates Ltd will see its PPA expire in July.

Both the heavy fuel oil-based 100MW quick rental power plants came into operation a decade ago.

The companies applied to the government for contract extension for another five years.

A decade ago, the government had largely embraced the quick rental and rental power generation strategy to urgently meet the then power crisis.

A decade later, the country is now running with abundant power and the government in principle has decided not to buy power from quick rental plants after the expiration of their existing contracts.

The development has turned to be a bane for listed companies who depend on such plants for revenue and earnings.

Khulna Power Company Ltd, the first ever private sector power producer, is an example of the problem being faced by stock market investors, as its two plants went off grid last week and the company is pursuing a contract renewal.

Meanwhile, the Bangladesh Securities and Exchange Commission has requested the government to rethink its decision not to renew the PPA with quick rental plants, especially the ones owned by listed companies.

Bangladesh / Economy / Top News

Orion Pharma / Power subsidiaries

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Another headwind the world does not need
  • Former U.S. President Donald Trump speaks at the Conservative Political Action Conference in Orlando, Florida, U.S. February 28, 2021. REUTERS/Octavio Jones/File Photo
    Trump to face criminal charges, sending US into uncharted waters
  • FILE PHOTO: The new UN High Commissioner for Human Rights Volker Turk, of Austria, poses in his office at the Palais Wilson, during a photocall for his taking official functions as United Nations High Commissioner for Human Rights in Geneva, Switzerland October 17, 2022. Salvatore Di Nolfi/Pool via REUTERS
    UN rights chief calls for immediate suspension of DSA, citing 'ongoing media crackdown'

MOST VIEWED

  • IBBL organises Iftar mahfil on 40th anniversary
    IBBL organises Iftar mahfil on 40th anniversary
  • JCI Dhaka Dynamic to train 21 visually impaired people
    JCI Dhaka Dynamic to train 21 visually impaired people
  • IPDC officers up to 90% loan facility on Audi purchase
    IPDC officers up to 90% loan facility on Audi purchase
  • Photo: Courtesy
    Huawei, bKash strengthen partnership to support SDGs
  • Emirates passengers can seamlessly travel to over 150 US points
    Emirates passengers can seamlessly travel to over 150 US points
  • Exclusive GP Star offers enhances luxury lifestyle with Le ROYAL
    Exclusive GP Star offers enhances luxury lifestyle with Le ROYAL

Related News

  • Orion Pharma greets FCPS doctors
  • Orion Pharma: Un-Audited Half Yearly (Q2) Financial Statements
  • Orion Pharma awards 5 doctors for winning Football World Cup quiz contest
  • Orion Pharma holds strategic meeting for 2023
  • Orion Pharma: Price Sensitive Information

Features

Photo: DW

How German are the British royals?

10h | Panorama
The exterior of the Crown RS Advance is sleek and modern, with a long body, sharp lines and an aggressive front grille. Photo: Akif Hamid

The Toyota Crown RS Advance: The luxury sedan for car enthusiasts

11h | Wheels
Illustration: TBS

'If local investors think the regulatory framework is uncertain, foreigners would doubly think so'

11h | Panorama
Illustration: TBS

A year on, the country's first transgender UP chairman serves people with humility

13h | Panorama

More Videos from TBS

Pakistan's matches in the World Cup could take place in Bangladesh

Pakistan's matches in the World Cup could take place in Bangladesh

23h | TBS SPORTS
Putin launches nuclear drills with Yars missile

Putin launches nuclear drills with Yars missile

1d | TBS World
Hritika's dream, transgenders will establish by studying

Hritika's dream, transgenders will establish by studying

13h | TBS Stories
People are waiting to cross the Padma Bridge by train

People are waiting to cross the Padma Bridge by train

1d | TBS Stories

Most Read

1
Nusrat Ananna and Nafis Ul Haque Sifat. Illustration: TBS
Pursuit

The road to MIT and Caltech: Bangladeshi undergrads beat the odds

2
Sadeka Begum. Photo: Courtesy
Panorama

Sadeka's magic lamp: How a garment worker became an RMG CEO

3
Photo: Bangladesh Railway Fans' Forum
Bangladesh

Bus-train collides at capital's Khilgaon on Monday night

4
Photo: Wikimedia Commons
Tech

Microsoft-owned Github fires entire Indian engineering team

5
Representational image
Bangladesh

Airport Road traffic to be restricted on Fridays from 31 March

6
Photo: Texas A&M
Science

Massive asteroid expected to pass by Earth this weekend

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]